Investment Q&A

Q: This week Pfizer spun-out Viatris as a Reverse Morris Trust Transaction. I understand the purpose of this type of transaction is to make it non-taxable. Are there income tax consequences for a Canadian citizen who owned Pfizer at the time of the spin-out?
Are Viatris shares worth holding?

Q: Hello

Can you comment on their most recent earnings and their prospects overall? I am a physician and I find some of their products very helpful so I am considering investing in the company.

Peter

Q: Hi there,
From my understanding these two companies are similar. Of course MGNI is smaller, soaring and according to MS is at fair value. While TTD is double MS fair value.

It was mentioned that TTD would have been Peter's Top Pick #4 on the last BNN visit.
So given all this... would you suggest MGNI (I have a 1/3 position already) or TTD? Many thanks.

Q: Looking to invest in the electric vehicle/battery space. Would appreciate your opinion on these ETF's, any preference or other ETF's to consider. Thanks for a great service. Brian

Q: Hi Team,

I have been watching on the sidelines as crsr sails away, especially after their big earnings beat. With REAL disappointing the market today would it be advisable to sell half of Real to buy into crsr? Thanks

Q: What companies will benefit most by providing the logistics for distribution of the virus vaccine? Would Americold Trust, COLD be one of these companies?

Q: What are your thoughts of Viatris (combination of Mylan and Upjohn)? Shares were received from Pfizer. I'd looked at Mylan recent quarterly statements and did not see any red flags. Looking forward what is its potential? Hold or sell? Thank you.

Q: Hi folks. Thank you for all your expertise. I have SNOW and would like to either add CRWD OR PANW but was wondering if they are similar to SNOW. Can you please advise if it's worth one or just stick with SNOW. Thanks Dan

Q: Are you familiar with this company and its transaction with Golden Nugget Online Gaming? Would this be a good buy or a speculative buy?

Craig

Q: Comments any your opinion please on NVDA latest earnings. Market reaction seemed pretty subdued.
Thank you

Q: Is there a great deal of difference between ayx and pltr in terms of what they do?
How much does ayx deserve to be in the penalty box for their recent results/outlook? You seem to have cooled off on this name considering recent answers.
Thanks

Q: Hello Folks:
I owned Costco for a number of years, however moved into Loblaw as Costco has become so expensive. Costco continues moving higher while Loblaw remains stagnant. Is it unreasonable to switch back to Costco, or are there better options?
Thank you for your good service!
brian

Q: What is your opinion of ARK Innovation ETF. Is now a good entry point if you think it is a good investment

Q: I own a full position in FTNT and in RPD in a registered account. The holding is for 10 years +++ Would you be inclined to switch one of the two for CRWD , which one and why? There would be no fees associate to the trade (no tax implication and trading fees are not significative relative to the size of the position)
if not, why?

Q: Peter was on BNN and recommended above two stocks. I am planning to invest these two stocks. Should I step in with full position at this price?

Thanks,

Q: Hello Folks:
As the Covid situation has hastened the move to online shopping, some brick and mortar stores are going to have a much brighter future than others. Businesses such as Walmart and Best Buy appear to be having more success than others. I would appreciate your suggestions on choosing companies which have the brightest future integrating these two systems.
Thank you again for your great service!
brian

Q: Hello,

What would be your favorite healthcare stocks in the US other then technology/healthcare stocks

Thank you

Q: I have owned AYX for a year - its been an exciting ride with the stock peaking 66% higher than its current price (I did not sell) I find myself back to where I started. In your view, how much of this volatility is due to management erring on the side of conservative guidance and thus tempering market enthusiasm and how much is a reevaluation by the street that perhaps there are better growth opportunities out there. Since it is part of my US High Growth portfolio, I am perfectly fine with the volatility if it is still on track. My question is, if this were in your US High Growth portfolio would you be keeping it or replacing it with a higher conviction name. If your answer is to replace it, what would be your top 2 names.

Many Thanks
Scott

Q: I have been holding BIIB for a couple of years on hopes (I know, that is not an investment strategy) that their alzheimer drug would be approved. It has come close a few times and the stock has reacted very favourably only to fall short of approval and fall back in price. Do you believe that the recent setback will make BIIB dead money for the foreseeable future and its best to move on or is it too cheap and compelling a story to sell now? If BIIB was part of your US Growth portfolio would you keep it or sell in favour of a better growth stock. If your decision would be to sell, what would be the top 2 names for replacement with no regard to sector.

Thanks
Scott

Q: this company seems to be gathering momentum in the right type of industry for current times seems to have a low PE havent been able to aquire much information whats your opinion going forward or is there another similar company that you might reccomend